Over the last two decades, the number of Americans with kidney cancer has risen each year. The most common type of kidney cancer, renal cell carcinoma (RCC), generally affects people between 50 and 70 years of age. With new treatment options available, those affected by advanced RCC have more reasons to feel hopeful. Dr. Saby George, who specializes in the treatment of kidney, bladder and prostate cancers and Dena Battle, President of KCCure tell us why.
As kidney cancer rates rise new treatment option may help
Posted: 1:21 PM, May 30, 2018
Updated: 2018-05-30 19:21:33Z
Copyright 2018 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.